Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, A.
Right arrow Articles by Calne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, A.
Right arrow Articles by Calne, D.
NEUROLOGY 1980;30:1244
© 1980 American Academy of Neurology

Aging and CSF hydroxylase cofactor

Adrian Williams, M.D., M.R.C.P., James Ballenger, M.D., Robert Levine, B.A., Walter Lovenberg, Ph.D. and Donald Calne, D.M., F.R.C.P.

Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke (Drs. Williams and Caine), the Section on Biochemical Pharmacology, National Heart, Lung and Blood Institute (Mr. Levine and Dr. Lovenberg), National Institutes of Health, and the Psychobiology Branch, National Institute of Mental Health (Dr. Ballenger), Bethesda, MD.

The level of cerebrospinal fluid (CSF) hydroxylase cofactor activity was measured in 34 neurologically normal patients and analyzed according to age. Levels declined by approximately one-third over a 40-year span, probably reflecting loss of aminergic neurons. Fourteen patients with Parkinson disease all tended to have lower values than age-matched controls. Among Parkinson patients with the same order of disability, younger cases had higher CSF concentrations of hydroxylase cofactor than older patients.

Address correspondence and reprint requests to Dr. Calne, Experimental Therapeutics Branch, Room 6D20, Clinical Center, NIH, Betheeda, MD 20205.

Accepted for publication January 3, 1980.




This article has been cited by other articles:


Home page
NeurologyHome page
Y. Furukawa, T. G. Nygaard, M. Gutlich, A. H. Rajput, C. Pifl, L. DiStefano, L. J. Chang, K. Price, M. Shimadzu, O. Hornykiewicz, et al.
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
Neurology, September 1, 1999; 53(5): 1032 - 1032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.